The current biology of resistin

Journal of Internal Medicine

Volumn 255, Issue 4, 2004, Pages 439-447

  Steppan, Claire M ^a   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adipokines; Adipose; Diabetes mellitus; Insulin resistance; Obesity; Resistin

Indexed keywords

GLUCOCORTICOID; GLUCOSE; INSULIN; RESISTIN; THYROID HORMONE;

3' UNTRANSLATED REGION; ADIPOCYTE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GENE LOCATION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HORMONES, ECTOPIC; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MICE; OBESITY; RESISTIN;

EID: 1842506529     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01306.x     Document Type: Review

References (64)

1. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
2. Kim K-H, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252-6.
3. Holcomb IN, Kabakoff RC, Chan B et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19: 4046-55.
4. Rajala MW, Lin Y, Ranalletta M et al. Cell type-specific expression and coregulation of murine resistin and resistinlike molecule-alpha in adipose tissue. Mol Endocrinol 2002; 16: 1920-30.
5. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
6. Makimura H, Mizuno TM, Bergen H, Mobbs CV. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab 2002; 283: E1266-71.
7. Juan CC, Au LC, Fang VS et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001; 289: 1328-33.
8. Chen L, Nyomba BL. Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Endocrinology 2003; 144: 500-8.
9. Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-6.
10. Levy JR, Davenport B, Clore JN, Stevens W. Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am J Physiol Endocrinol Metab 2002; 282: E626-33.
11. Le Lay S, Boucher J, Rey A et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 2001; 289: 564-7.
12. Li J, Yu X, Pan W, Unger RH. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 2002; 282: E1334-41.
13. Savage DB, Sewter CP, Klenk ES et al Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199-202.
14. Kawashima J, Tsuruzoe K, Motoshima H et al. Insulin downregulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003; 46: 231-10.
15. Shojima N, Sakoda H, Ogihara T et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002; 51: 1737-44.
16. Haugen F, Jorgensen A, Drevon CA, Trayhurn P. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 105-8.
17. Way JM, Gorgun CZ, Tong Q et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by PPARγ agonists. J Biol Chem 2001; 276: 25651-3.
18. Zhong Q, Lin CY, Clarke KJ, Kemppainen RJ, Schwartz DD, Judd RL. Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 296: 383-7.
19. Reynolds RM, Walker BR. Human insulin resistance: the role of glucocorticoids. Diabetes Obes Metab 2003; 5: 5-12.
20. Masuzaki H, Paterson J, Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-70.
21. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Isoproterenol inhibits resistin gene expression through a Gs-protein-coupled pathway in 3T3-L1 adipocytes. FEBS Lett 2001; 500: 60-3.
22. Karlander SG, Khan A, Wajngot A, Torring O, Vranic M, Efendic S. Glucose turnover in hyperthyroid patients with normal glucose tolerance. J Clin Endocrinol Metab 1989; 68: 780-6.
23. Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Dieguez C. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 2003; 11: 408-14.
24. Gabriely I, Ma XH, Yang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002; 51: 2951-8.
25. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N. Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 2002; 34: 622-8.
26. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46-7.
27. McTernan PG, McTernan CL, Chetty R et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407.
28. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003; 300: 674-8.
29. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003; 88: 1730-6.
30. Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA. Mechanisms regulating adipocyte expression of resistin. J Biol Chem 2002; 277: 19754-61.
31. Song H, Shojima N, Sakoda H et al. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules. Biochem Biophys Res Commun 2002; 299: 291-8.
32. Fukui Y, Motojima K. Expression of resistin in the adipose tissue is modulated by various factors including peroxisome proliferator-activated receptor alpha. Diab Obes Metab 2002; 4: 342-5.
33. Moore GB, Chapman H, Holder JC et al. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem Biophys Res Commun 2001; 286: 735-41.
34. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530: 158-62.
35. Fujita H, Fujishima H, Morii T et al. Effect of metformin on adipose tissue resistin expression in db/db mice. Biochem Biophys Res Commun 2002; 298: 345-9.
36. Patel L, Buckels AC, Kinghorn IJ et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-6.
37. Ghosh S, Singh AK, Aruna B, Mukhopadhyay S, Ehtesham NZ. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 2003; 305: 27-34.
38. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003; 111: 225-30.
39. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 skeletal muscle cells independent of changes in insulin signaling components and glut-4 translocation. Am J Physiol Endocrinol Metab 2003; 285: E106-15.
40. Jove M, Planavila A, Cabrero A et al. Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. Metabolism 2003; 52: 351-5.
41. Yuzuriha H, Inui A, Goto K, Asakawa A, Fujimiya M, Kasuga M. Intracerebroventricular administration of NPY stimulates resistin gene expression in mice. Int J Mol Med 2003; 11: 675-6.
42. Morash BA, Willkinson D, Ur E, Wilkinson M. Resistin expression and regulation in mouse pituitary. FEBS Lett 2002; 526: 26-30.
43. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001; 288: 1027-31.
44. Gerstmayer B, Kusters D, Gebel S et al. Identification of RELM-gamma, a novel resistin-like molecule with a distinct expression pattern small star, filled. Genomics 2003; 81: 588-95.
45. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285: 561-4.
46. Yura S, Sagawa N, Itoh H et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003; 88: 1394-7.
47. Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 2002; 34: 671-3.
48. Cao H, Hegele RA. Single nucleotide polymorphisms of the resistin (RSTN) gene. J Hum Genet 2001; 46: 553-5.
49. Tan MS, Chang SY, Chang DM, Tsai JC, Lee YJ. Association of resistin gene 3′-untranslated region +62G → A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocrinol Metab 2003; 88: 1258-63.
50. Osawa H, Onuma H, Murakami A et al. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 2002; 51: 863-6.
51. Sentinelli F, Romeo S, Arca M et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 2002; 51: 860-2.
52. Pizzuti A, Argiolas A, Di Paola R et al. An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 2002; 87: 4403-6.
53. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 2520-4.
54. Engert JC, Vohl MC, Williams SM et al. 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629-34.
55. Ma X, Warram JH, Trischitta V, Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 4407-10.
56. Urbanek M, Du Y, Silander K et al. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003; 52: 214-7.
57. 7 Youn BS, Yu KY, Park HJ et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 150-6.
58. Fujinami A, Obayashi H, Ohta K et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004; 339: 57-63.
59. McTernan PG, Fisher FM, Valsamakis G et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098-106.
60. Degawa-Yamauchi M, Bovenkerk JE, Jullar BE et al. Serum resistin (FIZZ3) protein is incresed in obese humans. J Clin Endocrinol Metab 2003; 88: 5452-5.
61. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-5.
62. Zhang JL, Qin YW, Zheng X, Qiu JL, Zou DJ. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 2003; 20: 828-31.
63. Azuma K, Katsukawa F, Oguchi S et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001.
64. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611-8.